- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ANTEOTECH LTD: Cleansing Notice under section 708A | - | ASX | ||
| Mo | ANTEOTECH LTD: Application for quotation of securities - ADO | - | ASX | ||
| 08.04. | Australia's Anteotech falls on discounted placement | 1 | Reuters | ||
| 08.04. | ANTEOTECH LTD: Proposed issue of securities - ADO | - | ASX | ||
| 08.04. | ANTEOTECH LTD: AnteoTech $6.4m Capital Raising | - | ASX | ||
| 04.04. | ANTEOTECH LTD: Trading Halt | 1 | ASX | ||
| 27.03. | ANTEOTECH LTD: AnteoTech secures $1.4m Qld Grant Funding | 1 | ASX | ||
| 04.03. | ANTEOTECH LTD: Settlement of Ferroglobe claim | - | ASX | ||
| 28.02. | ANTEOTECH LTD: Company Update | 1 | ASX | ||
| 27.02. | ANTEOTECH LTD: Half Yearly Report and Accounts | - | ASX | ||
| 23.02. | ANTEOTECH LTD: Half Yearly Results Timing & Investor Update Call | 1 | ASX | ||
| 14.02. | ANTEOTECH LTD: Anteo X Production Facility Completed | - | ASX | ||
| 29.01. | ANTEOTECH LTD: Quarterly Activities/Appendix 4C Cash Flow Report | 1 | ASX | ||
| 22.12.23 | ANTEOTECH LTD: Change of Director's Interest Notice | 1 | ASX | ||
| 22.12.23 | ANTEOTECH LTD: Notification of cessation of securities - ADO | 1 | ASX | ||
| 19.12.23 | ANTEOTECH LTD: GICS reclassification | 1 | ASX | ||
| 11.12.23 | ANTEOTECH LTD: Industry Presentation & New Technical Data | - | ASX | ||
| 05.12.23 | ANTEOTECH LTD: Commercialisation Milestone | - | ASX | ||
| 17.11.23 | ANTEOTECH LTD: Change of Director's Interest Notice x 5 | 1 | ASX | ||
| 17.11.23 | ANTEOTECH LTD: Notification regarding unquoted securities - ADO | 1 | ASX |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 39,700 | -1,24 % | EQS-News: Formycon AG: Formycon gibt Markteinführung von FYB201 (Ranibizumab) in Kanada (RanoptoTM) und der Schweiz (Ranivisio®) bekannt | EQS-News: Formycon AG
/ Schlagwort(e): Markteinführung
Formycon gibt Markteinführung von FYB201 (Ranibizumab) in Kanada (RanoptoTM) und der Schweiz (Ranivisio®) bekannt
11.04.2024... ► Artikel lesen | |
| VEECO INSTRUMENTS | 32,000 | -1,23 % | Veeco Instruments Inc.: Veeco Announces Date for First Quarter Financial Results and Conference Call | ||
| KOPIN | 1,179 | -1,34 % | KOPIN CORP - 8-K, Current Report | ||
| ONTO INNOVATION | 168,00 | -1,75 % | Here's How Much $100 Invested In Onto Innovation 5 Years Ago Would Be Worth Today | ||
| XTPL | 30,500 | 0,00 % | EQS-News: XTPL S.A.: XTPL liefert weiteres Industriemodul an HB Technology | Emittent / Herausgeber: XTPL S.A.
/ Schlagwort(e): Vereinbarung
XTPL liefert weiteres Industriemodul an HB Technology
18.04.2024 / 09:15 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
| ACACIA RESEARCH | 4,420 | -2,64 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 75,50 | -1,31 % | Dividendenbekanntmachungen (26.01.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) CITIZENS & NORTHERN CORPORATION US1729221069 0,28 USD 0,2581 EUR DORCHESTER MINERALS LP US25820R1059 1,0078 USD 0,9291 EUR ENLINK... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,392 | 0,00 % | ADVANCE ZINCTEK LIMITED: US Sales | ||
| NANOFOCUS | 0,510 | 0,00 % | Nanofocus: Investor verlängert die Frist | Die Carl Mahr Holding hat im März ein freiwilliges öffentliches Erwerbsangebot für die Aktien von Nanofocus abgegeben. Geboten werden dabei 0,50 Euro je Aktie von Nanofocus. Ursprünglich konnten Investoren... ► Artikel lesen | |
| RIBER | 2,660 | +1,14 % | RIBER: Strong growth in 2023 full-year earnings | Strong growth in 2023 full-year earnings Revenues: €39.3m (+41%) driven by the robust development of systems (+96%)Operating income: €3.9m, representing 10% of revenuesNet income: €3.4m, representing... ► Artikel lesen | |
| NANOVIRICIDES | 1,070 | -1,83 % | NanoViricides, Inc.: NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon | SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly... ► Artikel lesen | |
| ZENTEK | 1,030 | +0,98 % | Zentek Ltd.: Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions | GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce... ► Artikel lesen | |
| GOMSPACE | 0,325 | -5,11 % | GOMSPACE A/S: Notice to attend the annual general meeting in GomSpace Group AB (publ) | ||
| REGION GROUP | 1,295 | +0,43 % | REGION GROUP: Change in substantial holding from MUFG | ||
| NANOFORM FINLAND | 2,490 | 0,00 % | Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024 |
ANTEOTECH LTD gehört der Branche Nanotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
